BioArctic AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 10:30:00 13/03/2026 pm IST			5-day change	1st Jan Change
302.40 ^SEK	-1.43%		+1.20%	-2.70%

12/03	Scandibio recruits 200 patients for Phase 3 Alzheimer's study	FW
11/03	BioArctic partner to present long-term lecanemab data at AD/PD conference	FW

Published on 08/28/2025 at 09:13 pm IST - Modified on 08/29/2025 at 02:53 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Welcome to BioArctic Q2 Report 2025. [Operator Instructions] Now I will hand the conference over to CEO, Gunilla Oswald; and CFO, Anders Martin-Lof.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

12/03	Scandibio recruits 200 patients for Phase 3 Alzheimer's study	FW
11/03	BioArctic partner to present long-term lecanemab data at AD/PD conference	FW
20/02	Nordea Raises Price Target for Bioarctic to 240 Kronor (236), Reiterates Sell	FW
19/02	Lannebo Health and New Technology Down 5.1 Percent in January — Bico and Raysearch Weigh on Performance	FW
19/02	Goldman Sachs Raises Price Target for Bioarctic to 367 Kronor (346), Reiterates Buy - BN	FW
18/02	Stockholm Stock Exchange Hits All-Time High on Wednesday, OMXS30 Index Up 1.2 Percent	FW
18/02	Stockholm Stock Exchange Continues Upward Trend at Lunchtime, OMXS30 Index Rises 0.7 Percent	FW
18/02	Bioarctic AB Proposes Dividend for the Financial Year 2025	CI
18/02	BioArctic AB, Q4 2025 Earnings Call, Feb 18, 2026
18/02	Eight Stocks Reach New 52-Week Highs Today on the Stockholm Stock Exchange	FW
18/02	BioArctic AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
18/02	Stockholm Bullets – Bioarctic Rises on Better-Than-Expected Report	FW
18/02	Bioarctic Surprises with Operating Profit, Announces Dividend (Update)	FW
18/02	Bioarctic proposes dividend of 2.00 SEK per share for 2025	RE
18/02	Bioarctic Surprises with Operating Profit, Proposes Dividend	FW